426 patients: 31 molecular GB, 294 IDH-wild-type GB, 50 IDH-mutant astrocytoma, and 51 IDH-mutant 1p19q-codeleted oligodendroglioma. This evidence concerns the gene IDH1 and astrocytoma (excluding glioblastoma).